Found 14 matching trials
Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population
NAThis is a laboratory-blinded study in healthy toddlers, children, and teena...
Location
National Taiwan University Hospital
H1N1 Vaccine at Two Dose Levels in HIV Positive Adults
PHASE2The purpose of this study is to see how the body reacts to different streng...
Location
University of Iowa
Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients
N/AThe patients of pediatric haemato-oncology have a higher risk for novel H1N...
Location
National Taiwan University Hospital
Safety Trial of Monovalent Whole Virus Influenza (H1N1) Vaccine
PHASE1The study hypothesis is that two 0.5 ml doses of non-adjuvanted whole virio...
Location
Ben Luc Health Center
Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders
NAThis was a randomized, laboratory-blinded study in healthy male and non-pre...
Location
National Taiwan University Hospital
Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations
PHASE2The purpose of this study is to see how the body reacts to different streng...
Location
Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases
Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults
N/AThis study will evaluate the immunogenicity and safety of inactivated H1N1 ...
Location
St.Jude Children's Research Hospital
Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
PHASE2The 2009 flu pandemic is a global outbreak of a new strain of influenza A v...
Location
Shanghai Public Health Clinical Center
Novartis H1N1 Vaccine in Pregnant Women
PHASE2The purpose of this study is to evaluate the safety of a 2009 H1N1 influenz...
Location
University of Maryland Baltimore
Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children
PHASE4A total of 51 children between the ages of 4 and 9 will be randomized to re...
Location
University of Rochester Medical Center, Vaccine Research Unit Room 3-5000